A Randomised Prospective Study Assessing Changes in Neurocognitive Function, Using a Computerised Test Battery, in Treatment naïve HIV-1 Positive Subjects Commencing Two Different Antiretroviral Regimens

Trial Profile

A Randomised Prospective Study Assessing Changes in Neurocognitive Function, Using a Computerised Test Battery, in Treatment naïve HIV-1 Positive Subjects Commencing Two Different Antiretroviral Regimens

Completed
Phase of Trial: Phase IV

Latest Information Update: 04 Jul 2014

At a glance

  • Drugs Nevirapine (Primary) ; Atazanavir; Nucleoside reverse transcriptase inhibitors; Ritonavir
  • Indications HIV-1 infections
  • Focus Pharmacodynamics
  • Acronyms Cog Naive
  • Most Recent Events

    • 07 Jun 2017 Biomarkers information updated
    • 20 May 2014 Status changed from recruiting to completed, as per ClinicalTrials.gov record.
    • 25 May 2010 Additional lead trial investigator (Stephen Taylor) identified as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top